2Fearnley JM,Lees AJ.Ageing and Parkinson's disease:substantia nigra regional selectivity.Brain,1991,114:2283～2301.
3De Rijk MC,Launer LJ,Berger K,et al.Prevalence of Parkinson's disease in Europe:A collaborative study of population-based cohorts.Neurologic Diseases in the Elderly Research Group.Neurology,2000,54:S21～23.
4Bennett DA,Beckett LA,Murray AM,et al.Prevalence of parkinsonian signs and associated mortality in a community population of older people.N Engl J Med,1996,334:71～76.
5Zhang ZX,Roman GC,Hong Z,et al.Parkinson's disease in China:prevalence in Beijing,Xian,and Shanghai.Lancet,2005,365:595～597.
6Zbang ZX,Romau GC.Worldwide occurrence of Parkinson's disease:an updated review.Neuroepidemiology,1993,12:195～208.
7Peters CM,Gartner CE,Silburn PA,et al.Prevalence of Parkinson's disease in metropolitan and rural Queensland:a general practice survey.J Clin Neurosci,2006,13:343～348.
8Jenkins AC.Epidemiology of parkinsonism in Victoria.Med J Aust,1966,2:496～502.
9McCann SJ,LeCouteur DG,Green AC,et al.The epidemiology of Parkinson's disease in an Australian population.Neuroepidemiology,1998,17:310～317.
10Chan DK,Dunne M,Wong A,et al.Pilot study of prevalence of Parkinson's disease in Australia.Neuroepidemiology,2001,20:112～117.
